SIG
ABBV icon

Stanford Investment Group’s AbbVie ABBV Stock Holding History

Stanford Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-144
Closed -$8K – 329
2015
Q3 		$8K Hold
144
– – 0.01% 281
2015
Q2 		$10K Hold
144
– – 0.01% 282
2015
Q1 		$8K Hold
144
– – 0.01% 296
2014
Q4 		$9K Buy
+144
New +$9.08K 0.01% 291

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stanford Investment Group's ABBV Position: Q4 2015 in Review

Stanford Investment Group sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 144 shares — an estimated $8K sold.

Stanford Investment Group first reported a position in ABBV in Q4 2014 and held it in 4 quarters. The position peaked at $10K in Q2 2015. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Stanford Investment Group reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Stanford Investment Group sold 144 AbbVie shares in Q4 2015, an estimated $8K.
  • Stanford Investment Group first reported a position in AbbVie in Q4 2014 and held it in 4 quarters.
  • Stanford Investment Group's AbbVie position peaked at $10K in Q2 2015.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Stanford Investment Group's 13F filing for Q4 2015, filed 10 Nov 2016.